Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice - Wikidata - wikimedia - TriplyDB

Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice

Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice

http://www.wikidata.org/entity/Q34649842

about

Functional changes in pulmonary arterial endothelial cells associated with BMPR2 mutations Molecular pathogenesis of pulmonary arterial hypertension Targeting BMP signalling in cardiovascular disease and anaemia BMPR2 spruces up the endothelium in pulmonary hypertension BMPs and their clinical potentials Leukotrienes in pulmonary arterial hypertension Pulmonary vascular disease related to hemodynamic stress in the pulmonary circulation.Inflammation, endothelial injury, and persistent pulmonary hypertension in heterozygous BMPR2-mutant mice Bmp2 and Bmp4 exert opposing effects in hypoxic pulmonary hypertension Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-beta-catenin and Wnt-RhoA-Rac1 pathways.A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects.Overexpression of human bone morphogenetic protein receptor 2 does not ameliorate monocrotaline pulmonary arterial hypertension.A rapid and sensitive bioassay to measure bone morphogenetic protein activity.Blocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertension.Challenges in the development of chronic pulmonary hypertension models in large animals Heart failure and pulmonary hypertension.The cancer theory of pulmonary arterial hypertension.Idiopathic pulmonary arterial hypertension.Schistosomiasis-induced experimental pulmonary hypertension: role of interleukin-13 signaling.Chronic allergic inflammation causes vascular remodeling and pulmonary hypertension in BMPR2 hypomorph and wild-type mice Redox Pioneer: Professor Joseph Loscalzo.Role of 15-lipoxygenase/15-hydroxyeicosatetraenoic acid in hypoxia-induced pulmonary hypertension.ID family protein expression and regulation in hypoxic pulmonary hypertension.Estrogens and development of pulmonary hypertension: interaction of estradiol metabolism and pulmonary vascular disease.Role of lipoxygenase metabolites of arachidonic acid in enhanced pulmonary artery contractions of female rabbits.New perspectives for the treatment of pulmonary hypertension Deletion of the sequence encoding the tail domain of the bone morphogenetic protein type 2 receptor reveals a bone morphogenetic protein 7-specific gain of function Hemodynamic and histologic characterization of a swine (Sus scrofa domestica) model of chronic pulmonary arterial hypertension Neonatal hyperoxia causes pulmonary vascular disease and shortens life span in aging mice Bone morphogenetic protein signaling protects against cerulein-induced pancreatic fibrosis.BMP pathway regulation of and by macrophages.Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension.Update in pulmonary hypertension 2005.Pathogenic mechanisms of pulmonary arterial hypertension.Mediators and modulators of pulmonary arterial hypertension.Role of the TGF-beta/Alk5 signaling pathway in monocrotaline-induced pulmonary hypertension.Vascular remodeling in pulmonary hypertension.Molecular pathogenesis of pulmonary arterial hypertension Protein Kinase C Inhibitors as Modulators of Vascular Function and their Application in Vascular Disease Dysfunctional intracellular trafficking in the pathobiology of pulmonary arterial hypertension.

P2860

Q24303490-393FFE82-8B6B-462B-82B6-D54422CF7756 Q24634317-1AA7614A-6D61-49E1-9A1A-11D648EEB921 Q26783734-0357E23C-E02B-432F-8F9F-0F65F02A6E91 Q26786834-E6258548-8383-4043-9B80-471BF36B9F7C Q26824827-FB037750-F433-4648-9068-C5C081638306 Q26853496-D553923E-1986-4B2A-B21E-DF2A6DF0C6E8 Q27687091-FD0A700F-29CC-4DD5-A66B-83A45C5847A1 Q28590362-D0939463-8675-404D-AF0C-34F477D61BF8 Q28594843-43B7BF9F-3BBF-40CF-8CC7-8CC80E0C3A96 Q30485381-57FAA6A5-1F86-4BD1-A712-AEEFF795B4E4 Q30544892-AA4A920E-ACF2-4C86-B329-3E711A495568 Q33265315-A44D6DAB-3020-42DC-B2C4-62BDC66E9FA6 Q33299610-B17BEE67-0790-4A91-BD60-F41759F0DCB4 Q33593640-8668A7E9-2C65-4DD3-8082-7D558C3EBADE Q33738598-485EA63F-D2FD-4727-85E4-D1D2CE67C8BF Q33761721-1B72ADCE-9D49-4728-8C08-5D34720DE90E Q33788493-DF332E2A-CE9F-4629-ADEB-CAAE81721F9E Q33815389-3A50D1BB-B361-4C6C-9F55-F8C53C573A4F Q34087045-C521FF13-8FDE-48F3-9303-1E0BBA8769B8 Q34199837-8666A38A-2AB6-4956-8C98-F168966798E0 Q34222592-EA47DDC5-55D5-4800-AFBD-A1DC0E4B8675 Q34254117-0291A740-0753-49B4-9F91-497B1A82C759 Q34429113-E3162B28-98A1-4A9F-81CA-E4BED532207C Q34524900-12D43376-869B-4F36-879E-7D9B3C8B686D Q34777747-358DE85F-5992-41D4-9A9C-BC7954EE88FC Q34903204-1A02549B-FA85-4D0F-92A6-A34FC64ED15F Q35014984-A6A72D1F-8CA5-4266-B85E-E7686A346B67 Q35069848-D908C60D-B60A-4C25-A0BF-B33FE5A0D433 Q35071381-B4D32284-3B60-4DDB-97D4-B822648CE438 Q35106679-7A4A8D3D-B226-4BA8-BDBC-2B78621EE4E8 Q35142695-E6840347-4FB3-401C-BFA2-423A73735169 Q35832692-E5656F5F-433A-458D-A824-C4FDC10AE0A0 Q36403168-EEB89A00-E13E-4AF0-9BE7-CC0887A26CA2 Q36447388-2BAF098B-535E-42C0-8917-E6494E4779F1 Q36477935-0472ACBF-7B8B-457A-9DCE-BB3DDC489FC1 Q36539476-4512C211-3F5B-44C5-958A-A407D419C294 Q36644607-32771C27-E200-4B29-A158-CA0632E9EF01 Q36736065-F8E6E99C-823A-4FFA-A0C4-E584F2AE8740 Q36748065-B2A0DE6F-BDFA-49C2-B04C-92596B05AB3D Q36761071-2547DAAF-982C-4F89-91A9-646E23D7C0A1

P2860

Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice

http://www.wikidata.org/entity/Q34649842

description

2005 nî lūn-bûn

@nan

2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice

@ast

Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice

@en

Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice

@nl

type

label

Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice

@ast

Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice

@en

Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice

@nl

prefLabel

Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice

@ast

Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice

@en

Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice

@nl

P1433

Q34649842-F3219072-9217-4CB4-B3ED-46C37C67298B

P1476

Q34649842-B6DDBFCE-7044-44A2-ADA1-23BA54F8BB38

P2093

Q34649842-071EEC0F-BE81-461D-8689-A9BFB7E8DCBC

Q34649842-AE3344F2-1066-4AE3-93C7-634116626AB6

Q34649842-CE015787-1812-4597-A908-7A7A22028F9C

Q34649842-D90AF3CD-A8A2-44E4-80FE-68F2CF71E5D8

Q34649842-E893D1DC-EAC9-412A-846E-7400718FC9B4

P2860

Q34649842-020EFE6F-F293-4DB9-BFF1-AD6F0B16FEEA

Q34649842-12ACECA2-6094-4880-9793-C273A91DDED9

Q34649842-2D91ACD7-40AA-499D-A03C-72CF63770CB7

Q34649842-2F601A4E-D7C9-49D7-B63A-657E15C86AEB

Q34649842-2F6AC6A5-893D-4739-8FDA-A497C7CA1A83

Q34649842-2FC00D59-17F8-444C-800D-E28FE458A1FD

Q34649842-41611D5B-D4D4-4B3C-880F-63841DF47DFB

Q34649842-4AE99317-3725-46DF-8E4F-03C92FC4BA92

Q34649842-545A2B3A-0735-4E1C-9512-D2382376A3EC

Q34649842-61B3313E-4995-49C4-A75F-1883316F5A6F

P304

Q34649842-F2935AA5-B387-4693-96E2-928898D4B13A

P31

Q34649842-8EA303AD-A74D-47D8-B1DC-32A14A85F353

P356

Q34649842-CB499E21-E8F1-4FAD-9F6F-886C2C7E1372

P407

Q34649842-28957DA2-82F8-47D0-A8B2-938806A49CB9

P433

Q34649842-75088F15-8BCB-4423-B8DA-2E6ABC4DCF92

P478

Q34649842-9FA8E616-B4BC-4DF5-A0E9-A8159BDDA938

P50

Q34649842-853DFAC8-089A-42B0-BB91-50668EF3E050

P577

Q34649842-AD38F0BB-2C90-438E-AF14-19F43141C57E

P5875

Q34649842-2F3C1F3D-1018-413E-88AC-E5CF7B14350D

P698

Q34649842-7FC8D162-A34F-4848-9A75-8DED1D977409

P932

Q34649842-822AC2F4-D503-4353-A70A-2C443F3E7A34

P356

CIRCULATIONAHA.104.492488

P1433

P1476

Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice

@en

P2093

Hideyuki Beppu

http://www.w3.org/2001/XMLSchema#string

John E Jones

http://www.w3.org/2001/XMLSchema#string

John F Keaney

http://www.w3.org/2001/XMLSchema#string

Yanli Song

http://www.w3.org/2001/XMLSchema#string

Ying-Yi Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Novel regulators of bone formation: molecular clones and activities

Bone: formation by autoinduction

Expression of 5-lipoxygenase in pulmonary artery endothelial cells

BMP type II receptor is required for gastrulation and early development of mouse embryos

Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides

The transforming growth factor-beta family

Bone morphogenetic proteins: multifunctional regulators of vertebrate development

Clinical classification of pulmonary hypertension.

BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension.

Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene.

P304

553-562

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.104.492488

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P50

Joseph Loscalzo

P577

2005-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7718176

http://www.w3.org/2001/XMLSchema#string

P698

16027259

http://www.w3.org/2001/XMLSchema#string

P932

1472405

http://www.w3.org/2001/XMLSchema#string